RecruitingEN originalLeukemia

Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The study aims to conduct a real-world investigation of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in China, assessing their diagnosis, treatment status, survival outcomes, and prognostic factors. The research will involve children diagnosed with Ph+ ALL between January 1, 2015, and December 31, 2024. Our objective is to understand the incidence and prognosis of CML-like ALL, compare the diagnostic and treatment differences between CML-like ALL and typical Ph+ ALL, and provide clinical evidence for standardized treatment of CML-like patients. Through a multicenter retrospective study, we hope to improve the diagnostic and treatment strategies for children with Ph+ ALL, enhancing patient survival rates and quality of life.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek od 1 miesiąca do 18 lat w momencie rozpoznania
  • •Potwierdzenie białaczki przez badania genetyczne (gen BCR::ABL)
  • •Regularne badania kontrolne podczas leczenia przy użyciu nowoczesnych testów
  • •Leczenie lekami ukierunkowanymi na białaczkę (imatinib, dasatinib lub inne)

✗ Disqualifies

  • •Inne formy białaczki niż typowa forma Ph+
  • •Nieregularne leczenie niezgodne z ustaloną strategią terapeutyczną
  • •Obecność lub przeszłość innych nowotworów złośliwych
  • •Brak tolerancji na leki stosowane w tej terapii lub inne przeciwwskazania

Simplified criteria — AI translation

Trial details

Minimum age
1 Month
Maximum age
18 Years
Last updated (source)
September 10, 2026
Sex
No restrictions

Locations (1)

The Children's Hospital of Zhejiang University School of Medicine

Hangzhou, China

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/11/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.